151 related articles for article (PubMed ID: 33002285)
21. Human intelectin-1 (ITLN1) genetic variation and intestinal expression.
Nonnecke EB; Castillo PA; Dugan AE; Almalki F; Underwood MA; De La Motte CA; Yuan W; Lu W; Shen B; Johansson MEV; Kiessling LL; Hollox EJ; Lönnerdal B; Bevins CL
Sci Rep; 2021 Jun; 11(1):12889. PubMed ID: 34145348
[TBL] [Abstract][Full Text] [Related]
22. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
[TBL] [Abstract][Full Text] [Related]
23. Expression and regulation of INTELECTIN1 in human granulosa-lutein cells: role in IGF-1-induced steroidogenesis through NAMPT.
Cloix L; Reverchon M; Cornuau M; Froment P; Ramé C; Costa C; Froment G; Lecomte P; Chen W; Royère D; Guerif F; Dupont J
Biol Reprod; 2014 Aug; 91(2):50. PubMed ID: 24943040
[TBL] [Abstract][Full Text] [Related]
24. Extensive variation in the intelectin gene family in laboratory and wild mouse strains.
Almalki F; Nonnecke EB; Castillo PA; Bevin-Holder A; Ullrich KK; Lönnerdal B; Odenthal-Hesse L; Bevins CL; Hollox EJ
Sci Rep; 2021 Jul; 11(1):15548. PubMed ID: 34330944
[TBL] [Abstract][Full Text] [Related]
25. High expression of GPR116 indicates poor survival outcome and promotes tumor progression in colorectal carcinoma.
Yang L; Lin XL; Liang W; Fu SW; Lin WF; Tian XQ; Gao YJ; Chen HY; Dai J; Ge ZZ
Oncotarget; 2017 Jul; 8(29):47943-47956. PubMed ID: 28624786
[TBL] [Abstract][Full Text] [Related]
26. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
27. Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma.
Kuraoka M; Amatya VJ; Kushitani K; Mawas AS; Miyata Y; Okada M; Kishimoto T; Inai K; Nishisaka T; Sueda T; Takeshima Y
Am J Surg Pathol; 2017 Aug; 41(8):1045-1052. PubMed ID: 28394802
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
Cao F; Wang S; Wang H; Tang W
Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance and prognostic implication of nuclear factor-κB activation in colorectal cancer.
Pyo JS; Kim EK
Pathol Res Pract; 2019 Aug; 215(8):152469. PubMed ID: 31201065
[TBL] [Abstract][Full Text] [Related]
30. ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment.
Au-Yeung CL; Yeung TL; Achreja A; Zhao H; Yip KP; Kwan SY; Onstad M; Sheng J; Zhu Y; Baluya DL; Co NN; Rynne-Vidal A; Schmandt R; Anderson ML; Lu KH; Wong STC; Nagrath D; Mok SC
Nat Commun; 2020 Jul; 11(1):3546. PubMed ID: 32669559
[TBL] [Abstract][Full Text] [Related]
31. Human intelectin-2 (ITLN2) is selectively expressed by secretory Paneth cells.
Nonnecke EB; Castillo PA; Johansson MEV; Hollox EJ; Shen B; Lönnerdal B; Bevins CL
FASEB J; 2022 Mar; 36(3):e22200. PubMed ID: 35182405
[TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of metastasis-related tumor markers in colorectal cancer].
Wan XB; Pan ZZ; Ren YK; Ding PR; Chen G; Wan DS
Ai Zheng; 2009 Sep; 28(9):950-4. PubMed ID: 19728913
[TBL] [Abstract][Full Text] [Related]
33. HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.
Chen F; Zhang L; Wu J; Huo F; Ren X; Zheng J; Pei D
Cell Death Dis; 2018 Dec; 9(12):1176. PubMed ID: 30518879
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-7 Exerts Antiangiogenic Effect on Colorectal Cancer via ERK Signaling.
Fan X; Liu M; Tang H; Leng D; Hu S; Lu R; Wan W; Yuan S
J Surg Res; 2019 Aug; 240():48-59. PubMed ID: 30909065
[TBL] [Abstract][Full Text] [Related]
35. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological significance of PD-L1 expression in colorectal cancer: Impact of PD-L1 expression on pFOXO1 expression.
Pyo JS; Ko SH; Ko YS; Kim NY
Pathol Res Pract; 2020 Feb; 216(2):152764. PubMed ID: 31836325
[TBL] [Abstract][Full Text] [Related]
37. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
[TBL] [Abstract][Full Text] [Related]
38. The Role of Beclin 1 and HER2 in Colorectal Carcinoma; An Immunohistochemical Study.
Gadallah MS; Dawood M; Abdou A
Asian Pac J Cancer Prev; 2024 Feb; 25(2):617-626. PubMed ID: 38415549
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
40. A systematic review and Bayesian meta-analysis assessing intelectin-1 in cancer patients and healthy individuals.
Paval DR; Di Virgilio TG; Skipworth RJE; Gallagher IJ
Front Oncol; 2024; 14():1198555. PubMed ID: 38482202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
